Absence of cell-surface EpCAM in congenital tufting enteropathy

Ulrike Schnell1, Jeroen Kuipers, James L Mueller

  • 1Department of Cell Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Insights

Mutations in the epithelial cell adhesion molecule (EpCAM) cause congenital tufting enteropathy (CTE). All EpCAM mutations disrupt cell-surface expression, leading to this severe newborn intestinal disease.

Area of Science:

  • Genetics
  • Cell Biology
  • Gastroenterology

Background:

  • Congenital tufting enteropathy (CTE) is a severe neonatal intestinal disorder.
  • Mutations in the epithelial cell adhesion molecule (EpCAM) gene are identified as the cause of CTE.
  • The mechanism by which diverse EpCAM mutations lead to CTE remains unclear.

Purpose of the Study:

  • To investigate the molecular consequences of various EpCAM mutations.
  • To understand why different EpCAM mutations result in the same disease phenotype (CTE).

Main Methods:

  • Analysis of EpCAM mutations, including a novel intronic variant.
  • Assessment of EpCAM protein localization (transmembrane domain, plasma membrane).
  • Investigation of EpCAM mutant stability (secretion, degradation).

Main Results:

  • Most EpCAM mutations disrupt the transmembrane domain.
  • Mutants lacking the transmembrane domain are not routed to the plasma membrane.
  • Truncated mutants are either secreted or degraded, leading to loss of cell-surface EpCAM.

Conclusions:

  • All identified EpCAM mutations result in a loss of functional cell-surface EpCAM.
  • This loss of cell-surface EpCAM is the unifying mechanism leading to congenital tufting enteropathy.
  • Understanding EpCAM processing is crucial for CTE pathogenesis.